RESEARCH PAPER
Prevalence of sexually transmitted infections and associated factors among male prisoners in Great Tehran Prison by active case finding
1
Social Determinants of Health Research Center, Amir-al-Momenin Hospital, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
2
Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran
3
Research Development Center, Arash Women Hospital, Tehran University of Medical Sciences, Tehran, Iran
4
Virology Research Center, National Institutes of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5
Health and Treatment Directorate of Prisons and Security and Corrective Measures Organization, Tehran, Iran
Submission date: 2022-04-01
Final revision date: 2022-09-04
Acceptance date: 2022-09-09
Publication date: 2024-11-30
Corresponding author
Seyedahmad Seyedalinaghi
Research Center for HIV/AIDS, Iranian Institute for Reduction Of High Risk Behaviors, Tehran University Of Medical Sciences
Research Center for HIV/AIDS, Iranian Institute for Reduction Of High Risk Behaviors, Tehran University Of Medical Sciences
HIV & AIDS Review 2024;23(4):349-354
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Sexually transmitted infections (STIs) are transferred from one person to another through sexual contact. Despite high rates of STIs in prisons, there is no sufficient screening, prevention, and treatment programs to prevent STIs transmission among prisoners. Due to the contact between prisoners and general population during visiting or after release, controlling STIs transmission among prisoners helps significantly decrease the rate of STIs in society. Therefore, recognizing and reducing risky behaviors among prisoners may have remarkable effects in this regard. This study was performed to evaluate the prevalence and risk factors of STIs among incarcerated men through clinical examination and molecular tests, and to recommend possible and proper solutions for controlling STIs in prisons.
Material and methods:
This was a cross-sectional study conducted among 139 incarcerated men in the Great Tehran Prison, Iran from January to September 2018. We aimed to evaluate the risk factors and prevalence of STIs among imprisoned men based on clinical and molecular findings initiated by active (screening prisoners with STIs’ symptoms complaints) case findings.
Results:
Among those screened, a total of 139 prisoners were found by active and passive case findings for STIs symptoms. They were examined by complete genital and anal examination, followed by molecular testing for a definite diagnosis. The mean age of participants was 33.4 years. During active and passive case findings, 27 (19.4%) prisoners reported abnormal urethral discharge, and 89 (59.5%) individuals claimed that they have had STIs, most of them gonorrhea. Furthermore, most of the prisoners were not aware of the possibility that their sexual partners could have an STI. Also, 104 (74.8%) prisoners had a history of drug use. In clinical examination, 15 (10.8%) individuals had abnormal urethral discharges. In molecular survey, 7 (5%) persons had gonorrhea, 3 (2.2%) had Chlamydia trachomatis, and 3 (2.2%) had Mycoplasma.
Conclusions:
Prisons are high-risk settings for transmission of STIs, while the prevention, screening, and treatment programs are not adequately developed. Educating prisoners about signs and symptoms, risk behaviors, STI preventive measures, regular screening of prisoners, and sufficient treatment can help control the STIs prevalence among the prisoners and, therefore, in the general population
Sexually transmitted infections (STIs) are transferred from one person to another through sexual contact. Despite high rates of STIs in prisons, there is no sufficient screening, prevention, and treatment programs to prevent STIs transmission among prisoners. Due to the contact between prisoners and general population during visiting or after release, controlling STIs transmission among prisoners helps significantly decrease the rate of STIs in society. Therefore, recognizing and reducing risky behaviors among prisoners may have remarkable effects in this regard. This study was performed to evaluate the prevalence and risk factors of STIs among incarcerated men through clinical examination and molecular tests, and to recommend possible and proper solutions for controlling STIs in prisons.
Material and methods:
This was a cross-sectional study conducted among 139 incarcerated men in the Great Tehran Prison, Iran from January to September 2018. We aimed to evaluate the risk factors and prevalence of STIs among imprisoned men based on clinical and molecular findings initiated by active (screening prisoners with STIs’ symptoms complaints) case findings.
Results:
Among those screened, a total of 139 prisoners were found by active and passive case findings for STIs symptoms. They were examined by complete genital and anal examination, followed by molecular testing for a definite diagnosis. The mean age of participants was 33.4 years. During active and passive case findings, 27 (19.4%) prisoners reported abnormal urethral discharge, and 89 (59.5%) individuals claimed that they have had STIs, most of them gonorrhea. Furthermore, most of the prisoners were not aware of the possibility that their sexual partners could have an STI. Also, 104 (74.8%) prisoners had a history of drug use. In clinical examination, 15 (10.8%) individuals had abnormal urethral discharges. In molecular survey, 7 (5%) persons had gonorrhea, 3 (2.2%) had Chlamydia trachomatis, and 3 (2.2%) had Mycoplasma.
Conclusions:
Prisons are high-risk settings for transmission of STIs, while the prevention, screening, and treatment programs are not adequately developed. Educating prisoners about signs and symptoms, risk behaviors, STI preventive measures, regular screening of prisoners, and sufficient treatment can help control the STIs prevalence among the prisoners and, therefore, in the general population
REFERENCES (21)
1.
World Health Organization. Global health sector strategy on sexually transmitted infections 2016-2021: toward ending STIs. Contract No.: WHO/RHR/16.09. Geneva: WHO; 2016.
2.
Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992; 19: 61-77.
3.
Looker KJ, Elmes JA, Gottlieb SL, Schiffer JT, Vickerman P, Turner KM, et al. Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis. Lancet Infect Dis 2017; 17: 1303-1316.
5.
SeyedAlinaghi S, Farhoudi B, Mohraz M, Golsoorat Pahlaviani F, Hosseini M, Farnia M, et al. Prevalence and associated factors of HIV infection among male prisoners in Tehran, Iran. Arch Iran Med 2017; 20: 356-360.
6.
Javanbakht M, Boudov M, Anderson LJ, Malek M, Smith LV, Chien M, et al. Sexually transmitted infections among incarcerated women: findings from a decade of screening in a Los Angeles County Jail, 2002-2012. Am J Public Health 2014; 104: e103-e109. DOI: 10.2105/AJPH.2014.302186.
7.
Kamarulzaman A, Reid SE, Schwitters A, Wiessing L, El-Bassel N, Dolan K, et al. Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners. Lancet 2016; 388: 1115-1126.
8.
Farhoudi B, SeyedAlinaghi S, Dadras O, Tashakoriyan M, Pouya MN, Gouya MM, et al. Health service provision for disease control among prisoners: a conceptual note. J Health Res 2020; 34: 353-358.
9.
Seyedalinaghi SA, Farhoudi B, Mohraz M, Mohammadi Firouzeh M, Hosseini M, Kamali K. Prevalence of HIV in a prison of Tehran by active case finding. Iran J Public Health 2017; 46: 431-432.
10.
United Nations. Transforming our world: the 2030 agenda for sustainable development. Department of Economic and Social Affairs 2015/2016. Available at: https://sdgs.un.org/2030agenda.
11.
Centers for Disease Control and Prevention. IDU/HIV Prevention, HIV/AIDS counseling and testing in the criminal justice system. Available at: http://www.cdc.gov/IDU/facts/c....
12.
Navadeh S, Mirzazadeh A, Gouya MM, Farnia M, Alasvand R, Haghdoost AA. HIV prevalence and related risk behaviours among prisoners in Iran: results of the national biobehavioural survey, 2009. Sex Transm Infect 2013; 89 (Suppl. 3): iii33.
13.
Kheirandish P, Seyedalinaghi SA, Hosseini M, Jahani MR, Shirzad H, Foroughi M, et al. Prevalence and correlates of HIV infection among male injection drug users in detention in Tehran, Iran. J Acquir Immune Defic Syndr 2010; 53: 273-275.
14.
Ziaee M, Sharifzadeh G, Namaee MH, Fereidouni M. Prevalence of HIV and hepatitis B, C, D infections and their associated risk factors among prisoners in Southern Khorasan Province, Iran. Iran J Public Health 2014; 43: 229-234.
15.
Dolan K, Wirtz AL, Moazen B, Ndeffo-Mbah M, Galvani A, Kin-ner SA, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet 2016; 388: 1089-1102.
16.
Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep 2021; 70: 1-187.
17.
Zachariah R, Harries AD, Chantulo AS, Yadidi AE, Nkhoma W, Maganga O. Sexually transmitted infections among prison inmates in a rural district of Malawi. Trans R Soc Trop Med Hyg 2002; 96: 617-619.
18.
Verneuil L, Vidal JS, Ze Bekolo R, Vabret A, Petitjean J, Leclercq R, et al. Prevalence and risk factors of the whole spectrum of sexually transmitted diseases in male incoming prisoners in France. Eur J Clin Microbiol Infect Dis 2009; 28: 409-413.
19.
Tavoschi L, Vroling H, Madeddu G, Babudieri S, Monarca R, Vonk Noordegraaf-Schouten M, et al. Active case finding for communicable diseases in prison settings: increasing testing coverage and uptake among the prison population in the European Union/European Economic Area. Epidemiol Rev 2018; 40: 105-120.
20.
Brown CK, Earley M, Shaikh R, Fickenscher J, Ott J, Person A, et al. Voluntary STD testing and treatment program at a metropolitan correctional facility: evaluation of test acceptability and associated risk factors. J Correct Health Care 2014; 20: 70-80.
21.
Nasirian M, Baneshi MR, Kamali K, Haghdoost AA. Estimation of prevalence and incidence of sexually transmitted infections in Iran; a model-based approach. J Res Health Sci 2015; 15: 168-174.
| eISSN: | 1732-2707 |
| ISSN: | 1730-1270 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
